AU2003230767A1 - Methods of promoting cell viability - Google Patents

Methods of promoting cell viability

Info

Publication number
AU2003230767A1
AU2003230767A1 AU2003230767A AU2003230767A AU2003230767A1 AU 2003230767 A1 AU2003230767 A1 AU 2003230767A1 AU 2003230767 A AU2003230767 A AU 2003230767A AU 2003230767 A AU2003230767 A AU 2003230767A AU 2003230767 A1 AU2003230767 A1 AU 2003230767A1
Authority
AU
Australia
Prior art keywords
methods
cell viability
promoting cell
promoting
viability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003230767A
Other languages
English (en)
Other versions
AU2003230767A8 (en
Inventor
Walter C. Low
Clifford J. Steer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota System
Original Assignee
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota Twin Cities, University of Minnesota System filed Critical University of Minnesota Twin Cities
Publication of AU2003230767A8 publication Critical patent/AU2003230767A8/xx
Publication of AU2003230767A1 publication Critical patent/AU2003230767A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003230767A 2003-04-02 2003-04-02 Methods of promoting cell viability Abandoned AU2003230767A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/009819 WO2004096123A2 (en) 2003-04-02 2003-04-02 Methods of promoting cell viability

Publications (2)

Publication Number Publication Date
AU2003230767A8 AU2003230767A8 (en) 2004-11-23
AU2003230767A1 true AU2003230767A1 (en) 2004-11-23

Family

ID=33415179

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003230767A Abandoned AU2003230767A1 (en) 2003-04-02 2003-04-02 Methods of promoting cell viability

Country Status (5)

Country Link
EP (1) EP1615497A2 (enExample)
JP (1) JP2006514097A (enExample)
CN (1) CN1770975A (enExample)
AU (1) AU2003230767A1 (enExample)
WO (1) WO2004096123A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772220B2 (en) 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
ES2339790T3 (es) 2004-08-30 2010-05-25 Seo Hong Yoo Efecto neuroprotector de udca solubilizado en modelo isquemico focal.
CA2584184A1 (en) 2004-10-15 2006-04-27 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
WO2014036379A2 (en) * 2012-08-31 2014-03-06 Metselex Bile acids prevent or abolish progression of parkinson's and related neurodegenerative diseases
US9872865B2 (en) 2013-03-24 2018-01-23 Amylyx Pharmaceuticals Inc. Compositions for improving cell viability and methods of use thereof
TR201815345T4 (tr) 2013-07-01 2018-11-21 Bruschettini Srl Nörodejenertif hastalıkların tedavisinde kullanıma yönelik tauroursodeoksikolik asit (tudca).
CN109628379A (zh) * 2018-12-18 2019-04-16 西安交通大学 一种动物克隆胚胎培养液及培养方法
US11583542B2 (en) 2019-12-16 2023-02-21 Amylyx Pharmaceuticals, Inc. Compositions of bile acids and phenylbutyrate compounds
CN116262121A (zh) * 2021-12-15 2023-06-16 南湖实验室 牛磺熊去氧胆酸及其钠盐在抗衰老和/或延长寿命中的应用
US12138272B2 (en) 2022-05-12 2024-11-12 Amylyx Pharmaceuticals, Inc. Methods and compositions for treating amyotrophic lateral sclerosis

Also Published As

Publication number Publication date
JP2006514097A (ja) 2006-04-27
EP1615497A2 (en) 2006-01-18
CN1770975A (zh) 2006-05-10
AU2003230767A8 (en) 2004-11-23
WO2004096123A2 (en) 2004-11-11
WO2004096123A3 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
AU2003302701A1 (en) Method of dynamically culturing embryonic stem cells
GB2404665B (en) Cell culture
AU2003260351A1 (en) Cell culture insert
AU2003216822A1 (en) Stem cell culture
AU2003290432A1 (en) T cell activating gene
AU2003230767A1 (en) Methods of promoting cell viability
AU2003253918A1 (en) Methods of modifying behavior of cd9-expressing cells
GB0304918D0 (en) Cell culture
GB0315262D0 (en) Methods of cell culture
AU2003293517A1 (en) Methods of determining embryo viability
GB2394477B (en) Cell culture
AU2004900673A0 (en) Modified cells and methods of using same
AU2003287943A1 (en) Biogeometry shapes and methodology for biological energy balancing
AU2003242208A1 (en) Method of cell culture
AU2003904490A0 (en) Methods of Improving Embryo Viability
AU2003213411A1 (en) Cells capable of differentiating into myocardium-like cells
GB0314561D0 (en) Cell culture
AU2003903009A0 (en) Cell selection and transplantation
AU2005900447A0 (en) Method of growing cells
AU2003903894A0 (en) Stem cell culture system
HK1089791A (en) Cell culture media
GB0319804D0 (en) Cell culture method
HK1100087A (en) Methods for production of regulatory t cells and uses thereof
AU2003906907A0 (en) Bioreactor
AU2003904042A0 (en) Bioreactor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase